A retrospective analysis of treatment of 113 patients with multiple hepatocellular carcinoma

医学 肝细胞癌 单变量分析 多元分析 肝功能 肝炎 内科学 乙型肝炎 生存分析 胃肠病学 回顾性队列研究 经导管动脉化疗栓塞 临床病理学 肿瘤科 肝癌 放射科 阶段(地层学) 存活率 外科
作者
Lu Chen,Ti Zhang,Yunlong Cui,Hongyuan Zhou,Huikai Li,Di Zheng,Peng Zheng
出处
期刊:Chinese Journal of Hepatobiliary Surgery [Chinese Medical Association]
卷期号:20 (01): 15-19
标识
DOI:10.3760/cma.j.issn.1007-8118.2014.01.005
摘要

Objective To review and analyze the clinicopathological features,the treatment and the prognosis of patients with multiple hepatocellular carcinoma.Methods The data of 113 patients with multiple hepatocellular carcinoma treated between Jan.to Dec.2009 at the Tianjin Medical University Cancer Hospital were reviewed.The overall survival and the independent risk factors related to survival of these patients were statistically analyzed.Results The 1-,2-,and 3-year overall survival rates of these patients were 36%,19%,and 11% respectively,and the median survival was 11.6 months.The 1-,2-,and 3-year survival rates of the radical hepatic resection group were 64%,45%,and 27%,which were significantly higher than those of the TACE group (33%,13%,and 7% respectively),and also those of the supportive treatment group (0%,0%,and 0% respectively).Univariate analysis showed that age,tumor location,hepatitis background,tumor size,total tumor number,treatment and ALT were prognostic factors of longterm survival for patients with multiple HCC.Multivariate analysis revealed that age,hepatitis,tumor size,tumor number,and type of treatment were independent risk factors related to survival.Conclusions Patients with multiple hepatocellular carcinoma who were in class B or C of the BCLC classification benefited from R0 hepatic resection,if their liver function could tolerate the operation.Age,hepatitis,tumor size,tumor number,treatment were independent risk factors of survival. Key words: Multiple hepatocellular carcinoma;  Liver resection;  Transcatheter arterial chemoembolization;  Supportive treatment ;  Prognosis

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
orixero应助koom采纳,获得10
1秒前
善学以致用应助edward采纳,获得10
2秒前
louis dai发布了新的文献求助10
2秒前
2秒前
所所应助好好学习采纳,获得10
2秒前
Ava应助合适熊猫采纳,获得30
3秒前
3秒前
星辰大海应助呃呃呃采纳,获得10
3秒前
4秒前
素素完成签到,获得积分10
4秒前
4秒前
捞月捕云发布了新的文献求助20
4秒前
开朗艳一发布了新的文献求助10
5秒前
瞬光完成签到,获得积分10
6秒前
脑洞疼应助王木木采纳,获得10
6秒前
微笑远航完成签到,获得积分10
7秒前
你好CDY完成签到,获得积分10
7秒前
您不疼发布了新的文献求助10
8秒前
8秒前
8秒前
9秒前
9秒前
qqq完成签到,获得积分10
9秒前
科研通AI6应助校长采纳,获得10
9秒前
研究水合物的小白完成签到 ,获得积分10
9秒前
子车茗应助科研通管家采纳,获得10
10秒前
子车茗应助科研通管家采纳,获得30
10秒前
蓝天应助科研通管家采纳,获得10
10秒前
成就觅翠应助科研通管家采纳,获得10
10秒前
蓝天应助科研通管家采纳,获得10
10秒前
科目三应助科研通管家采纳,获得10
10秒前
李爱国应助科研通管家采纳,获得10
10秒前
蓝天应助科研通管家采纳,获得10
11秒前
深情安青应助科研通管家采纳,获得10
11秒前
优秀猫咪应助科研通管家采纳,获得30
11秒前
所所应助carocarol采纳,获得10
11秒前
orixero应助科研通管家采纳,获得10
11秒前
研友_VZG7GZ应助YYY采纳,获得10
11秒前
无花果应助科研通管家采纳,获得10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各位详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
F-35B V2.0 How to build Kitty Hawk's F-35B Version 2.0 Model 2500
줄기세포 생물학 1000
The Netter Collection of Medical Illustrations: Digestive System, Volume 9, Part III - Liver, Biliary Tract, and Pancreas (3rd Edition) 600
INQUIRY-BASED PEDAGOGY TO SUPPORT STEM LEARNING AND 21ST CENTURY SKILLS: PREPARING NEW TEACHERS TO IMPLEMENT PROJECT AND PROBLEM-BASED LEARNING 500
2025-2031全球及中国蛋黄lgY抗体行业研究及十五五规划分析报告(2025-2031 Global and China Chicken lgY Antibody Industry Research and 15th Five Year Plan Analysis Report) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4476791
求助须知:如何正确求助?哪些是违规求助? 3934716
关于积分的说明 12207466
捐赠科研通 3589394
什么是DOI,文献DOI怎么找? 1973613
邀请新用户注册赠送积分活动 1011067
科研通“疑难数据库(出版商)”最低求助积分说明 904774